Breaking barriers between industry and digital mental health

The Turner Institute seeks to advance industry research partnerships to ensure that the transition from basic discovery to impact is seamless and sustainable. In the newly established Turner Industry Engagement and Translation Council, we will continue to build close industry ties and explore opportunities for commercial translation in the ever evolving world of digital mental health. Importantly, we will seek to bridge the gap between the community-based digital mental health approaches and clinical services.

The Council Board members have been chosen to reflect a broad array of expertise in the healthcare sector both nationally and internationally.

Simon Tucker - Chair

Simon Tucker has decades of pharmaceutical management and R&D experience, and has worked closely with the university sector.

As VP of Research at Biota Pharmaceuticals he oversaw the research and IP portfolios, set R&D strategy, and participated in multiple licensing deals, collaborative projects with major pharmaceutical companies and the discovery and progression of clinical candidates. He is a founder & former CEO at 360biolabs, and is currently CEO of Continuum Biosciences and Jumpstart-Fertility: two international biotechs focused on drugs to address metabolic diseases and female infertility, respectively.

Professor Shantha Rajaratnam

Professor Shantha Rajaratnam is the Deputy Director of the Turner Institute and the Turner Director of Engagement and Translation.

He is Chair of the Monash Sleep Network, and serves on the Board of the Sleep Health Foundation. He is a Program Leader in the Alertness CRC, which brings together 30 academic, industry and government organisations to solve the major societal challenges posed by sleep loss and circadian clock disruption.

As part of his role as Director of Engagement and Translation, Shantha oversees the Turner Clinics, which provide cutting-edge assessment and treatment approaches to the community and advanced training to health professionals.

Dr Vicky Au

Dr Vicky Au is National Lead for Engagement and Strategy at CSIRO Futures, where she is responsible for driving sustainable growth for the practice through advisory engagements, internal strategy and practice development, and overseeing marketing activities. Prior to this she was a Director with PwC Australia and PwC Hong Kong and Mainland China. Dr Au holds a doctorate in the field of physical sciences and engineering.

Dr Au has prior experience as a patent examiner under both the international (PCT) and Australian patent systems. She is a passionate advisor, leader and mentor with close to 20 years’ experience in the innovation ecosystem.

Dr Rob Grenfell

Dr Rob Grenfell is a public health physician and currently serves as Director of CSIRO’s Health and Biosecurity Business Unit. He leads a broad portfolio covering Nutrition, eHealth, Medtech and Diagnostics and Biosecurity.

Dr Grenfell has broad ranging public health experience including National Medical Director at BUPA Australia New Zealand; National Director Cardiovascular Health at the Heart Foundation; Strategic Health Advisor to Parks Victoria; Senior Medical Advisor at the Department of Health Victoria; Physician in charge of travel health BHP and General Practice. He has extensive professional networks in the area of digital health.

Mr Geoffrey Kempler

Geoffrey Kempler has led several biopharmaceutical companies as both CEO and non-executive director. He founded ASX and NASDAQ listed Alterity Therapeutics (formerly Prana Biotechnology) and served as the CEO and Chairman since 1997. Mr Kempler was appointed as a Non-Executive Chairman of Opthea Limited, an ASX listed drug development company developing innovative, biologics-based therapies for the treatment of eye diseases, in 2015.

Mr Kempler is a qualified psychologist with extensive experience in investment, business development, and technology commercialisation.

Professor Helena Teede

Professor Teede is Executive Director of Monash Partners Academic Health Sciences Centre and Director of the Monash Centre for Health Research and Implementation in the School of Public Health, Monash University. She is an Endocrinologist, a clinician-researcher and an NHMRC Practitioner Fellow.

Professor Teede has a leading role in research and translation including large scale randomised controlled trials and evidence synthesis, international guidelines, co-design of new models of care, implementation and scale-up. She is an internationally renowned expert in women’s reproductive health and has over 400 publications.

Dr David White

Dr David White is a physician scientist who specialised in Internal Medicine and Pulmonary Disease. He is the Chief Scientific Officer for Philips Respironics and is a Professor of Medicine, Part Time, at the Harvard Medical School. Dr White has extensive experience in the development of medical and consumer devices and technologies.

Dr White is an internationally renowned expert in the field of sleep disordered breathing. He is past President of the American Academy of Sleep Medicine and former Editor-in-Chief of the Journal SLEEP.